These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7442269)

  • 1. Experimental model of doxorubicin extravasation in the mouse.
    Dorr RT; Alberts DS; Chen HS
    J Pharmacol Methods; 1980 Nov; 4(3):237-50. PubMed ID: 7442269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Dorr RT; Snead K; Liddil JD
    Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Chen HS
    Cancer Chemother Pharmacol; 1980; 5(1):17-20. PubMed ID: 7460191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental skin necrosis produced by adriamycin.
    Rudolph R; Suzuki M; Luce JK
    Cancer Treat Rep; 1979 Apr; 63(4):529-37. PubMed ID: 445507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
    Vargel I; Erdem A; Ertoy D; Pinar A; Erk Y; Altundag MK; Gullu I
    Ann Plast Surg; 2002 Dec; 49(6):646-53. PubMed ID: 12461449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene.
    Daugherty JP; Khurana A
    Cancer Chemother Pharmacol; 1985; 14(3):243-6. PubMed ID: 3995685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of dermal toxicity of doxorubicin by liposome encapsulation.
    Forssen EA; Tökes ZA
    Cancer Treat Rep; 1983 May; 67(5):481-4. PubMed ID: 6850663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidote studies of vinorelbine-induced skin ulceration in the mouse.
    Dorr RT; Bool KL
    Cancer Chemother Pharmacol; 1995; 36(4):290-2. PubMed ID: 7628047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Stone A
    Cancer Treat Rep; 1985 Apr; 69(4):431-7. PubMed ID: 3995512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extravasation of dactinomycin, vincristine, and cisplatin: studies in an animal model.
    Buchanan GR; Buchsbaum HJ; O'Banion K; Gojer B
    Med Pediatr Oncol; 1985; 13(6):375-80. PubMed ID: 4046975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of experimental doxorubicin skin toxicity by beta-adrenergic compounds.
    Dorr RT; Alberts DS
    Cancer Res; 1981 Jun; 41(6):2428-32. PubMed ID: 7237439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathogenesis of skin and subcutaneous injury induced by adriamycin.
    Luedke DW; Kennedy PS; Rietschel RL
    Plast Reconstr Surg; 1979 Apr; 63(4):463-5. PubMed ID: 424456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing management of adriamycin extravasation.
    Barlock AL; Howser DM; Hubbard SM
    Am J Nurs; 1979 Jan; 79(1):94-6. PubMed ID: 252885
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxorubicin-induced skin necrosis in the swine model: protection with a novel radical dimer.
    Averbuch SD; Gaudiano G; Koch TH; Bachur NR
    J Clin Oncol; 1986 Jan; 4(1):88-94. PubMed ID: 3941333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of adriamycin skin necrosis: an experimental study.
    Cohen MH
    Cancer Treat Rep; 1979 Jun; 63(6):1003-4. PubMed ID: 466641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.